Chinese
Deep Analysis

Anthropic’s IPO Roadshow: What the S-1 Says and How Investors in Each Country Can Take Part

Anthropic has filed its S-1 and launched its roadshow at $70–$78 a share under the ticker ANT. Key numbers, governance and risks from the prospectus, plus how investors in the US, Australia, UK, Europe, Japan, Canada and Asia can take part.

Jacky Wang 12 min read 84 views

Written on 11 November 2026 (Sydney time) from public filings and reports available that day. The IPO has not priced and the registration statement is not yet effective, so dates, price and share counts can still change. This is not financial advice.

“Anthropic is about to go public” can now be stated with some precision. Anthropic, PBC, the company behind Claude, publicly filed its S-1 with the SEC on 26 October, filed a second amendment on 10 November and launched its roadshow the same day. Below are the facts that are settled, followed by how investors in different countries can take part.

What is confirmed so far

  • Filings: Anthropic announced its S-1 on 26 October 2026. Amendment No. 1 on 2 November added third-quarter numbers, and Amendment No. 2 on 10 November added the price range.
  • Exchange and ticker: Class A common stock on the Nasdaq Global Select Market under ANT.
  • Size: 825 million Class A shares, of which 801,351,354 are new shares from the company and 23,648,646 come from selling stockholders. Underwriters have a 30-day option on up to 123.75 million more shares (roadshow announcement).
  • Price range: $70 to $78 per share.
  • Underwriters: Goldman Sachs and Morgan Stanley lead, with J.P. Morgan, Citigroup, Barclays, Wells Fargo, BofA and many others.
  • Concurrent private placement: AMD, Broadcom, Google, Micron, Microsoft, NVIDIA and a TSMC entity agreed to buy $26.0 billion of non-voting Class N stock at the IPO price, outside the public offering.
  • Timing: CNBC reported on 10 November, citing people familiar with the plans, that pricing is set for 18 November and trading for 19 November (US Eastern). Fidelity’s guide also expects pricing on the evening of 18 November. In Sydney that is roughly the morning of 19 November for pricing and the early hours of 20 November for the first trade.

Key numbers from the prospectus

  • Revenue: $33.24 billion for the nine months to 30 September 2026, up about 1,200% year on year. Third-quarter revenue was about $17 billion, up roughly 47% on the prior quarter, a clear slowdown from 132% in Q1 and 144% in Q2 (CNBC, 2 November).
  • Losses: a nine-month net loss of about $104 billion, most of it, according to CNBC, from fair-value changes on convertible notes and derivative liabilities. The Q3 net loss was $23.29 billion.
  • Run-Rate Revenue: about $81 billion as of 31 October 2026, up $10 billion from 30 September, per the S-1/A. This is a company-defined operating metric (trailing 28-day consumption fees times 13, plus monthly subscription fees times 12), not GAAP revenue.
  • Large customers: customers contributing more than $100,000 on a trailing twelve-month basis grew from over 950 to over 11,900 in a year.
  • Compute commitments: about $895.4 billion of purchase commitments and leases, almost all for compute and infrastructure.
  • Use of proceeds: at the $74 midpoint, net proceeds from the company’s shares plus the private placement are estimated at about $84.6 billion, for general corporate purposes including compute, infrastructure and hiring, and possibly acquisitions.
  • Valuation: the last private round was the May 2026 Series H, $65 billion at a $965 billion post-money valuation. Using the roughly 13.09 billion shares the S-1/A expects to be outstanding after the offering, $70 to $78 implies about $916 billion to $1.02 trillion. CNBC, on a fully diluted basis, puts the top of the range at up to $1.405 trillion. The two methods differ a lot, so always ask which one a “trillion-dollar” headline uses.

An unusual governance structure

Buying ANT is not like buying a typical tech stock, and the prospectus spends many pages on why:

  • Public benefit corporation: Anthropic is a Delaware PBC and must balance shareholders’ financial interests, the interests of people affected by its conduct, and its stated public benefit: “the responsible development and maintenance of advanced AI for the long-term benefit of humanity.”
  • Long-Term Benefit Trust (LTBT): financially disinterested trustees hold a single Class T share that lets them elect and remove the Class T directors, who make up a majority of the board. Class T has no economic rights.
  • Founder voting control: a single Class F share, held by an LLC whose members are the seven co-founders, will carry 50.1% of total voting power on general matters, including electing the non-Class T directors.
  • Public Benefit Fund: shares equal to about 5% of fully diluted stock went to a wholly owned subsidiary, the Anthropic Public Benefit Fund.

The practical result for public investors: Class A shares give you the economics, but very little say. The trust picks most of the board and the founders’ 50.1% vote decides the rest.

Main risks

  • Losses and compute spending: revenue is growing fast, but so are compute costs, and nearly $900 billion of long-term commitments leave little room if growth slows. Quarter-on-quarter growth already dropped sharply in Q3.
  • A long risk section: CNBC counted more than 90 pages of risk factors, covering political headwinds, infrastructure dependence and the tension between safety and commercial goals. The filing also flags how concentrated advanced chip supply is in Taiwan and at TSMC.
  • Lock-ups: most existing holders are locked up for 180 days, and co-founders and holders of more than 0.5% for up to 365 days. About 3.6 billion shares may be released early, including up to 10% of holdings of directors, officers and employees from the first trading day.
  • First-day volatility: a hot IPO can open far above the offer price, or below it. The prospectus itself lists a retail allocation and ongoing retail interest as factors that could move the stock.
  • Scarce allocations: the company expects retail investors worldwide to receive up to 20% of the Class A shares offered. CNBC notes that is well above the typical 5% to 10%, but demand will be huge, and many applicants will get few or no shares.

Two ways in: IPO allocation vs buying after listing

  1. IPO allocation: before pricing, you submit an indication of interest through an eligible broker and, if allocated, pay the offer price. The upside is the offer price; the downside is that you may get nothing, and many brokers penalise “flipping”, meaning selling soon after listing.
  2. Buying after listing: any broker that trades Nasdaq stocks lets you buy at market once trading starts. No allocation lottery, but the price is whatever the market sets, which can be well above the offer price on day one.

Country by country

Anthropic published its list of international retail brokers and selling agents and says no other firm is authorised to offer, or advertise access to, the retail offers in those jurisdictions. Be wary of any platform outside that list promising you Anthropic IPO shares.

United States

The prospectus names Charles Schwab, Fidelity, Robinhood, Trade-PMR, SoFi and E*TRADE as retail selling group members. Published rules include:

  • Fidelity: at least $25,000 in eligible Fidelity assets; requests from 25 shares in 25-share steps up to 1,000,000; you must reconfirm on pricing night; allocations are tiered by customer relationship; selling within 15 calendar days counts as flipping and restricts future IPO access (Fidelity).
  • Robinhood IPO Access: individual brokerage accounts only, with retirement, joint and managed accounts excluded; random or proportional allocation; selling within 30 days can block IPO access for 60 days (Robinhood).
  • SoFi: a funded Self-Directed Invest account, no minimum balance, requests from one share, and restrictions for selling within 30 days (SoFi).

According to LivininHongKong, citing Fidelity, Fidelity’s offer period is expected to close at 4pm ET on 17 November. Each broker sets its own cut-off.

Australia

Australia has a formal retail offer under an Australian prospectus lodged with ASIC. It is a broker firm offer for non-institutional investors with an Australian address:

  • Brokers: CommSec is Lead Australian Retail Broker (you need an International Shares Account), alongside Bell Potter, LGT Wealth, Macquarie, Morgans, Morgan Stanley Wealth Management, Sharesies and Stake.
  • Dates (AEDT): opens 11 November, closes 5pm 17 November; final price 19 November; Nasdaq trading 20 November; settlement 21 November.
  • Notes: the size of the Australian tranche is not fixed and depends on demand, AAP reports. There is no ASX listing; the shares trade on Nasdaq in US dollars, so you carry currency risk.

For tax, Australian residents usually sign a W-8BEN for US shares, and gains are subject to Australian capital gains tax, with the 50% discount generally available to individuals holding more than 12 months. Cost and sale proceeds are converted to AUD. Check with your accountant.

United Kingdom

The UK retail offer runs through RetailBook, an FCA-authorised public offer platform, and launched on 10 November:

  • You must be resident and physically located in the UK and apply through a participating intermediary. Anthropic’s list names AJ Bell, eToro, Hargreaves Lansdown, Interactive Brokers, Interactive Investor, Revolut and Robinhood.
  • General investment accounts, ISAs, Lifetime ISAs, Junior ISAs, SIPPs and Junior SIPPs can be used. Some intermediaries take USD orders and others GBP; GBP buyers receive CDIs.
  • Applications close on 18 November, with each intermediary setting its own cut-off.

European Economic Area and Switzerland

Anthropic plans retail offers in Denmark, Finland, France, Germany, Ireland, the Netherlands, Norway, Spain and Sweden under a European prospectus to be approved by Germany’s BaFin, which also covers a Swiss public offer. Listed brokers include BNP Paribas, Deutsche Bank, eToro, flatexDEGIRO, ING, Interactive Brokers, Nordnet, Revolut, Saxo, Scalable Capital, Trade Republic and UBS. In other EEA states the offer is limited to qualified investors.

European retail investors are often blocked from US-domiciled ETFs because those funds lack a PRIIPs KID. That rule does not apply here, because ANT is a single stock.

Japan

The Japanese selling agents are Mitsubishi UFJ Morgan Stanley, Mizuho, Rakuten Securities and SBI Securities. Rakuten’s notice says its book-building lottery runs from 11 November to 2:00am on 19 November (Japan time), on the PC website only, settles in yen or dollars, is eligible for the NISA growth allowance and charges no purchase commission. If you win the lottery and do not cancel, the purchase goes through automatically.

Canada

Canada uses a PREP prospectus filed in every province and territory, with BMO, CIBC, RBC, Scotiabank, TD and Wealthsimple as dealers. Wealthsimple’s IPO help page describes a one-time enrolment and a hold on funds at the top of the range plus a buffer. Nothing can be sold until the final prospectus is receipted.

Hong Kong

Hong Kong is not on Anthropic’s retail list. Futu’s guide says US IPO allocations are mainly open to Hong Kong professional investors, while retail clients can buy after listing. For most Hong Kong investors, the realistic route is buying ANT on Nasdaq through a broker such as Futu, Tiger or Interactive Brokers once it trades.

Singapore

The prospectus is not registered with the Monetary Authority of Singapore, so shares can only be offered to institutional and accredited investors under sections 274 and 275 of the Securities and Futures Act. Ordinary retail investors will need to buy after listing.

Mainland China

This is the most restricted market. The mainland is not on the offer list, and, as 21st Century Business Herald reported, Tiger, Futu and similar brokers suspended new buying and deposits for mainland accounts from 12 June 2026 under China’s crackdown on cross-border brokerage, leaving only selling and withdrawals. The approved channels are QDII funds, Stock Connect and Wealth Management Connect:

  • Stock Connect covers Hong Kong-listed stocks only, so it cannot reach a Nasdaq-only listing.
  • QDII funds give you fund units, not shares. Whether a fund holds ANT depends on its mandate, manager or index, popular QDII funds often cap subscriptions, and listed QDII ETFs have at times traded more than 10% above their indicative value.
  • Personal FX quota: the $50,000 annual allowance per person cannot be used to buy overseas securities.

In practice there is no direct, compliant route for mainland investors in the near term; the thing to watch is whether QDII or index funds add ANT later.

Indirect exposure

  • Big shareholders: Amazon holds Anthropic convertible notes, and Google has an investment agreement and is part of the concurrent private placement. Anthropic is still a small slice of either company’s market value.
  • Other listed holders: a report carried by Tiger Brokers says Commonwealth Bank of Australia valued its Anthropic stake at more than $1 billion at the end of June, and SK Telecom is an early investor.
  • Index funds: whether and when ANT joins the Nasdaq-100 or S&P 500 depends on each index’s rules; there is no confirmed timetable.
  • Crypto perpetuals and CFDs: OKX, Binance and others have listed perpetual contracts tied to Anthropic’s valuation. These are not shares, carry no securities-law protection, and add borrowed-money and counterparty risk. Most investors should avoid them.

A checklist before you apply

  1. Read the prospectus or your local offer document, especially the risk factors and governance sections.
  2. Confirm your country is in the offer and your broker is on the authorised list.
  3. Open and verify your account early, fund it in US dollars if needed, and note your broker’s own deadline, which is usually earlier than the official one.
  4. Request only what you would be happy to hold at the offer price. At most brokers, asking for more does not improve your odds.
  5. Learn the flipping rules, because selling quickly can cost you future IPO access.
  6. Set a position limit. This is a loss-making, highly valued company with unusual governance, and no one knows how it will trade after day one.

Bottom line

Two things set this IPO apart. Retail investors get an unusually large share, with local retail offers in Australia, the UK, Europe, Japan and Canada. And what they buy is a public benefit corporation whose direction is firmly held by a trust and its founders. The first makes access wider; the second limits what shareholders can change after they buy. Whether to take part, and how much, comes down to your own view of the AI industry and of this company’s losses and compute spending.

Disclaimer: this article summarises public information and is not investment advice. Dates, pricing and rules are set by the official offering documents and your broker’s latest notices.

发表评论